Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy.
Niethammer AG, Wodrich H, Loeffler M, Lode HN, Emmerich K, Abdollahi A, Krempien R, Debus J, Huber PE, Reisfeld RA.
Niethammer AG, et al. Among authors: krempien r.
FASEB J. 2005 Jan;19(1):158-9. doi: 10.1096/fj.04-2355fje. Epub 2004 Oct 21.
FASEB J. 2005.
PMID: 15498893